Lucira Health, Inc.
LHDX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $299 | $896 | $385 | $385 |
| - Cash | $106 | $58 | $4 | $0 |
| + Debt | $3 | $26 | $1 | $4 |
| Enterprise Value | $196 | $863 | $382 | $389 |
| Revenue | $93 | $0 | $0 | $0 |
| % Growth | 34,492.9% | – | – | – |
| Gross Profit | $10 | -$2 | $0 | $0 |
| % Margin | 11% | -621.6% | – | – |
| EBITDA | -$61 | -$30 | -$7 | -$6 |
| % Margin | -65% | -10,966.5% | – | – |
| Net Income | -$65 | -$37 | -$9 | -$7 |
| % Margin | -69.7% | -13,903.7% | – | – |
| EPS Diluted | -1.86 | -1.04 | -0.56 | -0.44 |
| % Growth | -78.8% | -85.7% | -27.3% | – |
| Operating Cash Flow | -$101 | -$33 | -$7 | -$6 |
| Capital Expenditures | -$15 | -$19 | -$0 | -$0 |
| Free Cash Flow | -$116 | -$51 | -$7 | -$7 |